搜尋結果
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
CNBC· 16 小時前The study also comes after years of political pressure on Novo Nordisk and other drugmakers to ...
As yuan skids, markets bet more depreciation is in store
Reuters· 24 小時前China's yuan is sliding and market participants suspect authorities are deliberately but ...
Trump’s Truth Social-Linked Stock Pops 15%—His Shares Hit $3.3 Billion—But Big Questions Linger
Forbes· 3 日前Shares of the blank-check company linked to former President Donald Trump’s social media ...
Cathie Wood's ARK ETF is forming a bottoming pattern, poised for a breakout, according to ...
CNBC· 16 小時前In the exchange-traded fund space, one ticker has been as polarizing as they come since 2020 – ARKK. From March 2020 through ...
We're buying more of this health-care company amid an overdone sell-off
CNBC· 7 日前Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly ...
Wall Street heads into the final March trading week with momentum on its side and Dow 40,000 in ...
CNBC· 6 日前Wall Street is heading into the final trading week of March with momentum on its side. The ...
Stocks making the biggest moves premarket: Krispy Kreme, UPS, Micron Technology and more
CNBC· 2 日前Krispy Kreme began testing sales at some McDonald's locations in 2022, and their ...
German health ministry says Ozempic exports not a concern
Reuters· 7 日前Large volumes of diabetes drug Ozempic are not being exported from Germany, its health ministry ...
Site Map - CNBC.com
CNBC· 10 小時前Site mapArticlesyesterdayDow surges more than 450 points, S&P 500 closes at a fresh record: Live updatesCramer's Lightning ...
The quiet rally in energy continues, lifting our lone oil-and-gas stock higher
CNBC· 3 日前The sluggish start follows a powerful rally last week that sent the S & P 500 , Dow Jones ...